Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome
Study objectives: Patients with carpal tunnel syndrome (CTS) show manifestations of arterial abnormalities, including carotid intimal thickening and increased vascular stiffness. As carpal tunnel syndrome is associated with amyloidosis, we hypothesized that previously observed abnormalities can larg...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | American Heart Journal Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666602224000363 |
_version_ | 1797199854489829376 |
---|---|
author | Tuğçe İrgi Ömer Faruk Baycan Tolga Sinan Güvenç Fatma Betül Özcan Adem Atıcı Yusuf Yılmaz Mustafa Çalişkan |
author_facet | Tuğçe İrgi Ömer Faruk Baycan Tolga Sinan Güvenç Fatma Betül Özcan Adem Atıcı Yusuf Yılmaz Mustafa Çalişkan |
author_sort | Tuğçe İrgi |
collection | DOAJ |
description | Study objectives: Patients with carpal tunnel syndrome (CTS) show manifestations of arterial abnormalities, including carotid intimal thickening and increased vascular stiffness. As carpal tunnel syndrome is associated with amyloidosis, we hypothesized that previously observed abnormalities can largely be related with concomitant amyloidosis rather than CTS itself. Design: Prospective observational study. Setting: Medeniyet University Goztepe Hospital Participants: 61 patients with CTS (of whom 32 had biopsy-proven amyloidosis) and 36 healthy controls. Interventions: Subjects underwent ultrasound examinations for the measurement of coronary flow velocity reserve (CFVR), flow-mediated vasodilatation (FMD) and carotid intimal-media thickness (CIMT). Main outcome measures: Comparison of CFVR, FMD and CIMT in CTS patients with or without amyloidosis. Results: Patients with either CTS or CTS with concomitant amyloidosis (CTS-A) had significantly lower FMD (9.7 % ± 4.0 % in CTS and 10.3 % ± 4.6 % in CTS-A groups, p < 0.05 for both) and CFVR (2.4 (2.1–2.8) in CTS and 1.8 (1.6–2.1) in CTS-A groups, p < 0.001 for both) as compared to controls, while CIMT was only increased in CTS-A group (0.70 (0.60–0.80), p < 0.001). The reduction in CFVR was solely related to an increased basal flow velocity in CTS patients while there was also a reduced hyperemic flow velocity in patients with CTS-A. Conclusion: Most arterial phenomena in CTS patients could be attributable to concomitant amyloidosis, although endothelial dysfunction was present even in patients with CTS without amyloidosis. |
first_indexed | 2024-04-24T07:22:22Z |
format | Article |
id | doaj.art-b78585c07c6a4156891eea89f03e8717 |
institution | Directory Open Access Journal |
issn | 2666-6022 |
language | English |
last_indexed | 2024-04-24T07:22:22Z |
publishDate | 2024-05-01 |
publisher | Elsevier |
record_format | Article |
series | American Heart Journal Plus |
spelling | doaj.art-b78585c07c6a4156891eea89f03e87172024-04-21T04:14:33ZengElsevierAmerican Heart Journal Plus2666-60222024-05-0141100393Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndromeTuğçe İrgi0Ömer Faruk Baycan1Tolga Sinan Güvenç2Fatma Betül Özcan3Adem Atıcı4Yusuf Yılmaz5Mustafa Çalişkan6Istanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyIstanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyIstinye University School of Medicine, Department of Cardiology, Istanbul, Turkey; Corresponding author at: Maltepe, İstinye Üniversitesi Topkapı Kampüsü, Teyyareci Sami Sk. No.3, 34010 Zeytinburnu, Istanbul, Turkey.Istanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyIstanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyIstanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyIstanbul Medeniyet University School of Medicine, Department of Cardiology, Istanbul, TurkeyStudy objectives: Patients with carpal tunnel syndrome (CTS) show manifestations of arterial abnormalities, including carotid intimal thickening and increased vascular stiffness. As carpal tunnel syndrome is associated with amyloidosis, we hypothesized that previously observed abnormalities can largely be related with concomitant amyloidosis rather than CTS itself. Design: Prospective observational study. Setting: Medeniyet University Goztepe Hospital Participants: 61 patients with CTS (of whom 32 had biopsy-proven amyloidosis) and 36 healthy controls. Interventions: Subjects underwent ultrasound examinations for the measurement of coronary flow velocity reserve (CFVR), flow-mediated vasodilatation (FMD) and carotid intimal-media thickness (CIMT). Main outcome measures: Comparison of CFVR, FMD and CIMT in CTS patients with or without amyloidosis. Results: Patients with either CTS or CTS with concomitant amyloidosis (CTS-A) had significantly lower FMD (9.7 % ± 4.0 % in CTS and 10.3 % ± 4.6 % in CTS-A groups, p < 0.05 for both) and CFVR (2.4 (2.1–2.8) in CTS and 1.8 (1.6–2.1) in CTS-A groups, p < 0.001 for both) as compared to controls, while CIMT was only increased in CTS-A group (0.70 (0.60–0.80), p < 0.001). The reduction in CFVR was solely related to an increased basal flow velocity in CTS patients while there was also a reduced hyperemic flow velocity in patients with CTS-A. Conclusion: Most arterial phenomena in CTS patients could be attributable to concomitant amyloidosis, although endothelial dysfunction was present even in patients with CTS without amyloidosis.http://www.sciencedirect.com/science/article/pii/S2666602224000363AmyloidosisArteriopathyCarpal tunnel syndromeEndothelial dysfunctionMicrovascular dysfunction |
spellingShingle | Tuğçe İrgi Ömer Faruk Baycan Tolga Sinan Güvenç Fatma Betül Özcan Adem Atıcı Yusuf Yılmaz Mustafa Çalişkan Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome American Heart Journal Plus Amyloidosis Arteriopathy Carpal tunnel syndrome Endothelial dysfunction Microvascular dysfunction |
title | Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
title_full | Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
title_fullStr | Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
title_full_unstemmed | Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
title_short | Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
title_sort | concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome |
topic | Amyloidosis Arteriopathy Carpal tunnel syndrome Endothelial dysfunction Microvascular dysfunction |
url | http://www.sciencedirect.com/science/article/pii/S2666602224000363 |
work_keys_str_mv | AT tugceirgi concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT omerfarukbaycan concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT tolgasinanguvenc concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT fatmabetulozcan concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT adematıcı concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT yusufyılmaz concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome AT mustafacaliskan concomitantamyloidosisistheprimarycauseofendothelialandcoronarymicrovasculardysfunctionincarpaltunnelsyndrome |